Metal chaperones prevent zinc-mediated cognitive decline

[1]  A. Bush,et al.  A novel approach to rapidly prevent age-related cognitive decline , 2013, Aging cell.

[2]  A. Bush,et al.  Clioquinol Synergistically Augments Rescue by Zinc Supplementation in a Mouse Model of Acrodermatitis Enteropathica , 2013, PLoS ONE.

[3]  Blaine R. Roberts,et al.  Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export , 2012, Nature Medicine.

[4]  Miki Suzuki,et al.  Transient Increase in Zn2+ in Hippocampal CA1 Pyramidal Neurons Causes Reversible Memory Deficit , 2011, PloS one.

[5]  C. Masters,et al.  The Alzheimer’s therapeutic PBT2 promotes amyloid‐β degradation and GSK3 phosphorylation via a metal chaperone activity , 2011, Journal of neurochemistry.

[6]  A. Bush,et al.  Metal Ionophore Treatment Restores Dendritic Spine Density and Synaptic Protein Levels in a Mouse Model of Alzheimer's Disease , 2011, PloS one.

[7]  N. Oku,et al.  Impairment of recognition memory and hippocampal long-term potentiation after acute exposure to clioquinol , 2010, Neuroscience.

[8]  K. Blennow,et al.  PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. , 2010, Journal of Alzheimer's disease : JAD.

[9]  A. Bush,et al.  Cognitive Loss in Zinc Transporter-3 Knock-Out Mice: A Phenocopy for the Synaptic and Memory Deficits of Alzheimer's Disease? , 2010, The Journal of Neuroscience.

[10]  J. Russell,et al.  Synaptically Released Zinc Triggers Metabotropic Signaling via a Zinc-Sensing Receptor in the Hippocampus , 2009, The Journal of Neuroscience.

[11]  B. Barbour,et al.  Zinc at glutamatergic synapses , 2009, Neuroscience.

[12]  J. Koh,et al.  Essential Role for Zinc-Triggered p75NTR Activation in Preconditioning Neuroprotection , 2008, The Journal of Neuroscience.

[13]  K. Blennow,et al.  Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial , 2008, The Lancet Neurology.

[14]  C. Masters,et al.  Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ , 2008, Neuron.

[15]  J. McNamara,et al.  Zinc-Mediated Transactivation of TrkB Potentiates the Hippocampal Mossy Fiber-CA3 Pyramid Synapse , 2008, Neuron.

[16]  Yaping Zeng,et al.  Synaptic release of zinc from brain slices: Factors governing release, imaging, and accurate calculation of concentration , 2006, Journal of Neuroscience Methods.

[17]  A. Bush,et al.  The neurobiology of zinc in health and disease , 2005, Nature Reviews Neuroscience.

[18]  Alastair M. Hosie,et al.  Zn2+ Ions: Modulators of Excitatory and Inhibitory Synaptic Activity , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[19]  A. Mackinnon,et al.  Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. , 2003, Archives of neurology.

[20]  Jae-Young Koh,et al.  Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Masters,et al.  Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.

[22]  E. Shimizu,et al.  Genetic enhancement of learning and memory in mice , 1999, Nature.